CAVA Group, Inc. <CAVA.N>: JP Morgan cuts target price to $85 from $90
CAVA•Related News
Iveda partners with GlobalMed to deliver AI-driven situational awareness tools to US government agencies
IVDA•
Clean Harbors to buy EnviroServe for $470 million cash
CLH•
AMN Healthcare white paper sees persistent US staffing strain across clinicians through 2030
AMN•
Aprea Therapeutics Q2 net loss widens on higher R&D costs
APRE•
TotalEnergies reports 2.28 billion shares outstanding as of July 31, 2026
TTE•